Focus:
Cardiovascular
-
25 February 2020 News
Wearable AI sensor predicts worsening heart failure
A new artificial intelligence (AI) powered wearable sensor could help doctors remotely detect critical changes in heart failure patients days before any health crisis occurs.
-
21 February 2020 News
Cardiovalve’s Transcatheter Tricuspid Valve System gets FDA approval
The US Food and Drug Administration (FDA) has granted Breakthrough Device Designation for Israel-based medical device company Cardiovalve’s Transcatheter Tricuspid Valve Replacement System for tricuspid regurgitation (TR) indication.
-
20 February 2020 News
US researchers develop heart valve designed to grow with children
A new type of heart valve could remove the need for children with congenital heart disease to undergo multiple open-heart surgeries by growing alongside them.
-
19 February 2020 News
Endotronix enrols two patients for PROACTIVE-HF pivotal trial
US-based digital health and medical technology company Endotronix has enrolled first two patients in the PROACTIVE-HF pivotal trial, a pre-market investigational device-exempt (IDE) study evaluating the safety and efficacy of...
-
19 February 2020 News
Abbot receives CE mark for heart rhythm management devices
US-based health care and medical device company Abbott has secured CE Mark for its Gallant implantable cardioverter-defibrillator (ICD) and cardiac resynchronisation therapy defibrillator (CRT-D) devices in Europe.
-
14 February 2020 Comment
FDA approves Eko cardiology technology advances
Earlier this month, Eko, an artificial intelligence (AI) digital health company, was granted FDA approval for its latest cardio-technology. The US-based company has developed new algorithms for its novel AI...
-
10 February 2020 News
Caption Health’s cardiac ultrasound software gets marketing approval
Caption Health has secured authorisation from the US Food and Drug Administration (FDA) to market its cardiac ultrasound software.
-
6 February 2020 News
JenaValve raises equity financing funds for clinical programme
JenaValve Technology, manufacturer of JenaValve Pericardial Transcatheter Aortic Valve Replacement (TAVR) System to treat aortic valve disease, has raised $50m through an equity financing led by Bain Capital Life Sciences.
-
5 February 2020 News
Abbott’s implantable heart pump system gets FDA approval
Abbott has secured breakthrough device designation from the US Food and Drug Administration (FDA) for its in-development fully implantable heart pump system.
-
31 January 2020 News
Medtronic obtains European approval for Cobalt and Crome devices
Medtronic has secured European approval for its Cobalt and Crome portfolio of implantable cardioverter-defibrillators (ICD) and cardiac resynchronisation therapy-defibrillators (CRT-D).